Company profile

Ticker
XRAY
Exchange
CEO
Don M. Casey
Employees
Incorporated in
Location
Fiscal year end
Former names
Dentsply International Inc
SEC CIK
IRS number
391434669

XRAY stock data

(
)

Calendar

2 Aug 19
22 Sep 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Jun 19 Mar 19 Dec 18 Sep 18
Revenue 1.01B 946.2M 1.06B 946.2M
Net income 36.4M 39.2M 1.8M 28M
Diluted EPS 0.16 0.17 0.01 0.17
Net profit margin 3.61% 4.14% 0.17% 2.96%
Operating income 67.5M 47.3M 81.8M 45.5M
Net change in cash 24.7M -84.2M
Cash on hand 250.1M 225.4M 309.6M
Cost of revenue 468.6M 446.5M
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 3.99B 3.99B 0 0
Net income -1.01B -1.55B 429.9M 251.2M
Diluted EPS -4.51 -6.76 1.94 1.76
Net profit margin -25.36% -38.81%
Operating income -958.1M -1.56B 454.7M 375.2M
Net change in cash -11M -63.3M 99.3M 133M
Cash on hand 309.6M 320.6M 383.9M 284.6M
Cost of revenue 1.92B 1.8B 1.74B 1.16B

Financial data from company earnings reports

Financial report summary

?
Competition
Zimmer Biomet
Management Discussion
  • •For the year ended December 31, 2018, net sales decreased 0.2% compared to the year ended December 31, 2017. Net sales, excluding precious metal content, decreased 0.1% compared to the prior year. Net sales decreased 1.3% on a constant currency basis including a benefit of 0.5% from net acquisitions. Net sales, excluding precious metal content, were favorably impacted by approximately 1.3% due to the weakening of the U.S. dollar over the prior period.
  • •For the year ended December 31, 2018, the Company reported a net loss attributable to Dentsply Sirona of $1,011.0 million as compared to the net loss attributable to Dentsply Sirona of $1,550.0 million for the year ended December 31, 2017. The Company reported a net loss per share of $4.51 per share compared to a net loss per share of $6.76 in the prior year. On an adjusted basis (a non-US GAAP measure as defined under the heading “Net Income attributable to Dentsply Sirona”), full year 2018 net income decreased by $163.7 million or 26.5% compared to the prior year and earnings per diluted share declined 24.3% to $2.01 from $2.66 in the prior year.
  • •On November 5, 2018, the Board of Directors of the Company approved a plan to restructure the Company’s business to support revenue growth and margin expansion and to simplify its organization. The Company expects to incur approximately $275 million in one-time expenditures and charges.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: auto, basic, began, binding, capacity, Carolina, Charlotte, closed, confirm, count, Deferral, duty, fully, Gomez, head, headcount, highest, Human, intercompany, Jorge, Placement, PPN, proportional, repay, Stockholder, strategic, threshold, trailing, transformation, WACC
Removed: Castronovo, determination, estimate, existence, implementing, installment, integration, John, layered, mandatory, mix, multicurrency, obligated, Pennsylvania, record, representing, served